These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 25991507

  • 1. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
    Liu D, Zhang Q, Sun Y, Wang C, Zhang Y, Fu X, Chen M, Zhou G, Yu X, Wang J, Liu H, Zhang F.
    Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
    [Abstract] [Full Text] [Related]

  • 2. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
    Beltrán-Alzate C, López Díaz F, Romero-Montoya M, Sakamuri R, Li W, Kimura M, Brennan P, Cardona-Castro N.
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
    [Abstract] [Full Text] [Related]

  • 3. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
    Matsuoka M, Suzuki Y, Garcia IE, Fafutis-Morris M, Vargas-González A, Carreño-Martinez C, Fukushima Y, Nakajima C.
    Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
    [Abstract] [Full Text] [Related]

  • 4. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
    Sekar B, Arunagiri K, Kumar BN, Narayanan S, Menaka K, Oommen PK.
    Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY, Kang TJ, Kim SK, Lee SB, Chae GT.
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [Abstract] [Full Text] [Related]

  • 10. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI, Colorado CL, Torres JF, León CI.
    Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
    [Abstract] [Full Text] [Related]

  • 11. Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.
    Li X, Li G, Yang J, Jin G, Shao Y, Li Y, Wei P, Zhang L.
    Int J Mol Sci; 2022 Oct 18; 23(20):. PubMed ID: 36293307
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.
    Cambau E, Saunderson P, Matsuoka M, Cole ST, Kai M, Suffys P, Rosa PS, Williams D, Gupta UD, Lavania M, Cardona-Castro N, Miyamoto Y, Hagge D, Srikantam A, Hongseng W, Indropo A, Vissa V, Johnson RC, Cauchoix B, Pannikar VK, Cooreman EAWD, Pemmaraju VRR, Gillini L, WHO surveillance network of antimicrobial resistance in leprosy.
    Clin Microbiol Infect; 2018 Dec 18; 24(12):1305-1310. PubMed ID: 29496597
    [Abstract] [Full Text] [Related]

  • 14. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
    Lavania M, Singh I, Turankar RP, Ahuja M, Pathak V, Sengupta U, Das L, Kumar A, Darlong J, Nathan R, Maseey A.
    J Glob Antimicrob Resist; 2018 Mar 18; 12():214-219. PubMed ID: 29097343
    [Abstract] [Full Text] [Related]

  • 15. Evidence for Mycobacterium leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India.
    Mahajan NP, Lavania M, Singh I, Nashi S, Preethish-Kumar V, Vengalil S, Polavarapu K, Pradeep-Chandra-Reddy C, Keerthipriya M, Mahadevan A, Yasha TC, Nandeesh BN, Gnanakumar K, Parry GJ, Sengupta U, Nalini A.
    Am J Trop Med Hyg; 2020 Mar 18; 102(3):547-552. PubMed ID: 31933458
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases.
    Ahuja M, Singh I, Lavania M, Pathak VK, Darlong J, Turankar RP, Hembrom S, Singh SV, Sengupta U.
    J Glob Antimicrob Resist; 2022 Sep 18; 30():282-285. PubMed ID: 35717020
    [Abstract] [Full Text] [Related]

  • 18. Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.
    Vedithi SC, Malhotra S, Das M, Daniel S, Kishore N, George A, Arumugam S, Rajan L, Ebenezer M, Ascher DB, Arnold E, Blundell TL.
    Sci Rep; 2018 Mar 22; 8(1):5016. PubMed ID: 29567948
    [Abstract] [Full Text] [Related]

  • 19. Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy.
    Cambau E, Bonnafous P, Perani E, Sougakoff W, Ji B, Jarlier V.
    Clin Infect Dis; 2002 Jan 01; 34(1):39-45. PubMed ID: 11731943
    [Abstract] [Full Text] [Related]

  • 20. Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015.
    Chauffour A, Lecorche E, Reibel F, Mougari F, Raskine L, Aubry A, Jarlier V, Cambau E, CNR-MyRMA.
    Clin Microbiol Infect; 2018 Nov 01; 24(11):1213.e5-1213.e8. PubMed ID: 29906598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.